Sandoz ‘Bucks Trend’ With Completion Of GSK Cephalosporins Deal
CEO Richard Saynor Insists On The Importance Of Investing In Antibiotics
Sandoz has completed the acquisition of GSK’s cephalosporin antibiotics business which includes the Zinnat, Zinacef and Fortum brands in more than 100 markets. Commenting as the deal closed, Sandoz CEO Richard Saynor emphasized the importance of investing in antibiotics.
